{
    "name": "moxetumomab pasudotox",
    "comment": "Rx",
    "other_names": [
        "Lumoxiti",
        "moxetumomab pasudotox-tdfk"
    ],
    "classes": [
        "Antineoplastics",
        "Monoclonal Antibody"
    ],
    "source": "https://reference.medscape.com/drug/lumoxiti-moxetumomab-pasudotox-1000257",
    "pregnancy": {
        "common": [
            "There are no available data regarding use in pregnant women",
            "Based on mechanism of action and findings in nonpregnant female animals, moxetumomab pasudotox is expected to cause maternal and embryo-fetal toxicity when administered to pregnant women"
        ],
        "specific": [
            {
                "type": "Contraception",
                "description": [
                    "Women of reproductive potential should use effective contraception during treatment and for at least 30 days after the last dose"
                ]
            }
        ]
    },
    "lactation": {
        "common": [
            "No data are available regarding the presence of the drug in human milk or the effects on the breastfed child or milk production",
            "The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical need for the drug and any potential adverse effects on the breastfed child or from the underlying maternal condition"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": [
                {
                    "type": "Capillary leak syndrome",
                    "description": [
                        "Capillary leak syndrome (CLS), including life-threatening cases, reported",
                        "Monitor weight and blood pressure; check labs, including albumin, if CLS is suspected",
                        "Delay dosing or discontinue as recommended"
                    ]
                },
                {
                    "type": "Hemolytic uremic syndrome",
                    "description": [
                        "Hemolytic uremic syndrome (HUS), including life-threatening cases, reported",
                        "Monitor hemoglobin, platelet count, and serum creatinine, and ensure adequate hydration",
                        "Discontinue in patients with HUS"
                    ]
                }
            ]
        },
        "contraindicators": {
            "common": [
                "None"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "CLS, including life-threatening cases, reported and is characterized by hypoalbuminemia, hypotension, symptoms of fluid overload, and hemoconcentration (see Black Box Warnings, Dosage Modifications, and Dosing Considerations)",
                "HUS, including life-threatening cases, reported and is characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and progressive renal failure (see Black Box Warnings, Dosage Modifications, and Dosing Considerations)",
                "Renal toxicity has been reported; patients who experience HUS, those aged ≥65 yr, or those with baseline renal impairment may be at increased risk for worsening of renal function following treatment",
                "Infusion-related reactions may occur; symptoms include chills, cough, dizziness, dyspnea, feeling hot, flushing, headache, hypertension, hypotension, infusion-related reaction, myalgia, nausea, pyrexia, sinus tachycardia, tachycardia, vomiting, or wheezing; premediate with antihistamines and antipyretics; interrupt infusion if severe and treat with corticosteroids before resuming dose",
                "Electrolyte abnormalities reported; hypocalcemia is most commonly reported (see Dosing Considerations)"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Creatinine increased",
            "percent": "96"
        },
        {
            "name": "ALT increased",
            "percent": "65"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "64"
        },
        {
            "name": "AST increased",
            "percent": "55"
        },
        {
            "name": "Hypocalcemia",
            "percent": "54"
        },
        {
            "name": "Hypophosphatemia",
            "percent": "53"
        },
        {
            "name": "Infusion",
            "percent": "50"
        },
        {
            "name": "related reactions",
            "percent": "43"
        },
        {
            "name": "Hemoglobin decreased",
            "percent": "41"
        },
        {
            "name": "Neutrophil count decreased",
            "percent": "41"
        },
        {
            "name": "Hyponatremia",
            "percent": "39"
        },
        {
            "name": "Peripheral edema",
            "percent": "35"
        },
        {
            "name": "Nausea",
            "percent": "34"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "34"
        },
        {
            "name": "Fatigue",
            "percent": "33"
        },
        {
            "name": "Headache",
            "percent": "31"
        },
        {
            "name": "Pyrexia",
            "percent": "30"
        },
        {
            "name": "Blood bilirubin increased",
            "percent": "25"
        },
        {
            "name": "Hypokalemia",
            "percent": "25"
        },
        {
            "name": "GGT increased",
            "percent": "23"
        },
        {
            "name": "Hypomagnesemia",
            "percent": "23"
        },
        {
            "name": "Constipation",
            "percent": "21"
        },
        {
            "name": "Diarrhea",
            "percent": "21"
        },
        {
            "name": "Anemia",
            "percent": "21"
        },
        {
            "name": "Platelet count decreased",
            "percent": "21"
        },
        {
            "name": "Hyperuricemia",
            "percent": "20"
        },
        {
            "name": "Alkaline phosphatase increased",
            "percent": "15"
        },
        {
            "name": "Hemoglobin decreased",
            "percent": "14"
        },
        {
            "name": "Hypophosphatemia",
            "percent": "11-20"
        },
        {
            "name": "Neutrophil count decreased",
            "percent": "3.8-11"
        },
        {
            "name": "Platelet count decreased",
            "percent": "7"
        },
        {
            "name": "Hemolytic uremic syndrome",
            "percent": "10"
        },
        {
            "name": "Anemia",
            "percent": "8.8"
        },
        {
            "name": "Hyponatremia",
            "percent": "3.8"
        },
        {
            "name": "Infusion",
            "percent": "3.8"
        },
        {
            "name": "related reactions",
            "percent": "0.8-3"
        },
        {
            "name": "ALT increased",
            "percent": "2.5"
        },
        {
            "name": "Hemolytic uremic syndrome",
            "percent": "2.5"
        },
        {
            "name": "Nausea",
            "percent": "2.5"
        },
        {
            "name": "Creatinine increased",
            "percent": "1.6-2"
        },
        {
            "name": "Hyperuricemia",
            "percent": "1.3"
        },
        {
            "name": "Capillary leak syndrome",
            "percent": "1.3"
        },
        {
            "name": "Pyrexia",
            "percent": "1.3"
        },
        {
            "name": "Hypoalbuminemia",
            "percent": "1.3"
        },
        {
            "name": "AST increased",
            "percent": "1.3"
        },
        {
            "name": "Blood bilirubin increased",
            "percent": "1.3"
        },
        {
            "name": "Hypokalemia",
            "percent": null
        },
        {
            "name": "Hypomagnesemia",
            "percent": null
        }
    ]
}